Virender Kumar, Ph.D. is a Co-Founder and the Chief Scientific Officer of RPMH LCC, where he leads the company’s scientific research and development efforts. He is an expert of drug delivery, small molecule design, mRNA therapy, design of chemically stabilized oligonucleotides for in vivo delivery.
Bharti Sethi, M.S. is one of the founders of RMPH LCC. She is an expert in nanomedicine, molecular imaging, and drug delivery and leads RMPH's lead technologies. She hopes to continue promoting a healthy, active lifestyle through her work and daily life.
Ram Mahato, Ph.D. is a Professor at the University of Nebraska Medical Center and was a Senior Scientist at GeneMedicine, Inc., The Woodland, TX. He has an extensive experience in identifying the molecular mechanisms for cancers, and targeting their signaling pathways by innovative drug delivery approaches.